BB Biotech Navigates the Stormy Seas of Global Market Turbulence While Betting on the Future
BB Biotech reported a net loss of 241 million Swiss francs in Q1 2025, compared to a 260 million franc profit last year, due to volatile U.S. pharmaceutical markets and…
How a New Boston Biotech Plans to Halt Diseases Before They Even Start
Etiome, a biotech startup, secured a $50 million investment from Flagship Pioneering to transform healthcare by intercepting diseases before symptoms arise. Utilizing multiomics data, artificial intelligence, and electronic health records,…
Revolutionary Solution Emerges in Battle Against Fish Farm Pests
A Montreal-based company, EVAH, has developed an innovative feed additive that eliminates sea lice in fish farms. This breakthrough has secured a U.S. patent and promises to address longstanding ecological…
Revolutionizing Green Energy: The Malaysian Venture Bringing Microalgae Into the Limelight
CCESB and Oasis Xtract are pioneering a collaboration to revolutionize green energy through microalgae cultivation. Their innovative closed tank systems enable scalable and efficient microalgae production without reliance on sunlight.…
Scientific Collaboration: How India and Italy Are Pioneering the Future Together
India and Italy have signed an agreement to enhance scientific collaboration, focusing on quantum technology, artificial intelligence, and biotechnology. This partnership builds on 150 past collaborative projects and aims to…
The Race to the Biotech Future: How China Challenges Global Innovation
Biotechnology, integrating biology with technology, is a key area of innovation where China seeks global dominance. China's state-supported strategy includes acquiring, amplifying, and dominating global markets, challenging competitors through low…
The Surprising Diplomatic Power of Biotech: How China and Japan Forge New Paths Together
The biopharmaceutical industry is central to China's strategic goals, merging economic growth, public welfare, and national security. China shifts from producing generic drugs to innovating in life sciences, competing globally…
Unfolding the High-Stakes Drama: Could College Innovations Pay You Back?
The Trump administration's proposed reduction in federal payments poses a significant threat to research universities like Virginia Tech, with potential losses reaching $18 million annually. Indirect costs, essential for maintaining…
CDC Closures Leave Global Health Vulnerable: What’s Next in the Fight Against STDs?
The closure of a key CDC laboratory, initiated by the Trump administration, disrupts STI surveillance and the fight against drug-resistant strains, especially "super gonorrhea." The Gonococcal Isolate Surveillance Project (GISP),…
The Quiet Revolution: How Small Biotechs are Outpacing Big Pharma
In 2024, biotech firms were responsible for nearly two-thirds of new drug approvals by the U.S. FDA. Smaller biotechs are increasingly choosing market independence, challenging traditional Big Pharma dominance. Advancements…